US Patent Family Members and Approved Drugs for Japan Patent: 2960039
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: JP2960039
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,395,760 | 2012-03-07 | peginterferon alfa-2b | Merck Sharp & Dohme Corp. | PEGINTRON |
| 5,395,760 | 2012-03-07 | etanercept | Immunex Corporation | ENBREL |
| 5,605,690 | 2014-02-25 | etanercept | Immunex Corporation | ENBREL |
| 5,605,690 | 2014-02-25 | peginterferon alfa-2b | Merck Sharp & Dohme Corp. | PEGINTRON |
| 5,712,155 | 2009-09-05 | etanercept | Immunex Corporation | ENBREL |
| 5,945,397 | 2009-09-11 | peginterferon alfa-2b | Merck Sharp & Dohme Corp. | PEGINTRON |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
